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A post-operative diabetic patient who had been treated forSerratia marcescens bacterial sepsis
developed recurrent thrombosis of the left femoral artery following intra-arterial instrumenta-
tion. Pathological examination ofarterial thrombus ultimately demonstrated invasive mucormy-
cosis ofthe femoral artery and cultures ofthis material grew Rhizopus oryzae. The occurrence of
cutaneous and subcutaneous mucormycosis isreviewed, as well as recently recognized nosocomial
risk factors for mucormycosis, such as elasticized bandages and wound dressings.
CASE PRESENTATION
DR. JAN EVANS PATTERSON (Infectious Disease Fellow:) A 64-year-old diabetic white
man was admitted to the West Haven Veterans Administration Medical Center in July
1985 for coronary artery bypass graft surgery. The patient had a history of chronic
atrial fibrillation for at least three years. He received antimicrobial prophylaxis with
cephapirin during his surgery. An intra-aortic balloon pump (IABP) was inserted as he
was removed from extracorporeal circulation. The IABP was placed into his left
femoral artery via an extension of the incision which had been required to harvest his
left saphenous vein graft. It was removed on the first post-operative day. On that day,
hedeveloped sternal wounddrainage and routine povidone-iodine (Betadine) irrigation
ofthe wound was initiated. Elasticized bandages were used to cover the femoral artery
wound dressing. Cephapirin was continued. Five days post-operatively, he developed a
fever of 1010 F. The cephapirin was discontinued, and his blood, sputum, urine, and
sternal wound were cultured. At that time, he was started on parenteral ampicillin,
gentamicin, and clindamycin. Later that day he underwent mediastinal debridement.
Necrotic material was removed and purulent drainage from the sternal wound became
evident. Cultures of this material grew Serratia marcescens sensitive to cefoxitin,
mezlocillin, trimethoprim-sulfamethoxazole, and the aminoglycosides. Two blood
cultures grew the same organism, as did cultures obtained from his chest tube.
The Infectious Disease Service was called to see him regarding antibiotic therapy.
His physical examination at that time was remarkable for a rectal temperature of
1010 F, obesity, drainage from the sternal wound, clear lung fields, and atrial
fibrillation without a murmur. His abdominal exam was benign and his extremities
wereedematous, theleft lowerextremity slightly moresothan theright. The Infectious
Disease Service recommended therapy with mezlocillin, and he defervesced.
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Eight days post-operatively, his left leg was noted to be increasingly edematous and
slightly cyanotic. Both the edema and cyanosis were thought due to chronic arterial
insufficiency when evaluated by his vascular surgeons. He was already on intravenous
heparin, which had been started post-operatively because of atrial fibrillation. Two
days later he became hypotensive, requiring pressors to maintain blood pressure; he
developed a metabolic acidemia with an arterial pH in the range of 7.28 to 7.35. He
was intermittently hyperglycemic with serum glucoses measured in the range of
200-300 mg/dl. His white blood count rose from a baselineof20,000 to 29,000cells/,ul
and he was noted to have some drainage from his left inguinal wound incision. The
serum creatinine had risen to 6 mg/dl; the blood urea nitrogen was 112 mg/dl, and the
urine sediment was unremarkable. Peritoneal dialysis was started and tobramycin was
added to his antibiotic regimen. He underwent local debridement of the left groin
wound which contained necrotic material. Culture of this material grew Serratia
marcescenswith the same antibioticsusceptibility pattern as the blood and mediastinal
isolates. The left lower extremity had become cold and cyanotic. On post-operative day
11, he had extensive debridement of the left groin wound. A large amount of dead
tissue, including muscle, was noted. Two days after this debridement, his left lower
extremity was noted to be even colder and more cyanotic. There were no distal pulses
present. The vascular surgeons saw him and further debridement of his left groin
wound was performed.
DR. VINCENT T. ANDRIOLE (Chief, Infectious Disease Section): After the thrombec-
tomy was there any improvement in the left lower extremity?
DR. PATTERSON: No. There was no detectable pulse in his left lower extremity. After
thrombectomy it remained both cyanotic and cold. The vascular surgeons recom-
mended amputation, but the family declined.
DR. ANDRIOLE: In thinking about a differential diagnosis for the problems this patient
presented, several possibilities arise. This could have been a local post-operative
infection following the insertion of an IABP. The arterial occlusion could represent a
local inflammatory process. If this were the case, when thrombectomy was done there
should have been immediate improvement. Ifthere were a more serious problem, such
as invasion ofthevessel in addition tovascular thrombosis, then improvement after the
thrombectomy would be unlikely. We have to think about other organisms that are
known vascular invaders. That limits the etiology somewhat to Pseudomonas species
and certain fungi that are likely to invade the vessel wall itself.
DR. PATTERSON: What particular fungi would you be concerned about in such a case?
DR.ANDRIOLE: The most notorious vascular invaders are the Mucor species, which are
found in theorder Mucorales. In a diabetic, those andAspergillus species would be my
first considerations.
DR. PATTERSON: At this point, a pathology report on the thrombectomy specimen was
received. The specimen shown under low power is diagnostic (Fig. 1).
DR. ANDRIOLE: There are hyphae present throughout the specimen; we need to know
whether there are any septae, i.e., cross-walls within the hyphae, to distinguish
Aspergillus species from the non-septate Mucor species.
DR. PATTERSON: No septae are visible. A methenamine silver stain (Fig. 2) confirms
what was seen on the hematoxylin and eosin stains. These are non-septate hyphae
which branch at wide angles.
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FIG. 1. A low-power view
~~~~~~~~~ ~~~~~~~~of the patient's infected
,WS,,:-: F 't r~~~~~~~~ thrombectomy specimen in
which many hyphae (arrow)
~ were present throughout the
t ., Z* 5# .F .**>*;infectedthrombus.
A culture of the thrombectomy material grew Candida tropicalis and Rhizopus
oryzae, of the order Mucorales. A wet preparation of the Rhizopus obtained directly
from culture shows the sporangium and rhizoid structures (Fig. 3). In Rhizopus
species these root-like structures, or rhizoids, are directly below the sporangium. In
culture the organism has a loose woolly mycelium with black pinpoints, which are the
spore-filled sporangia. It fills the test tube within a few days. This is characteristic of
Rhizopus and other members ofthe order Mucorales.
The patient had a progressive downhill course, while the family continued to resist
allowing an amputation. He was started on parenteral amphotericin B at a dose of 50
mg per day. Approximately three days after the leg was found to be gangrenous, the
family finally agreed to an operation. A high above-the-knee amputation was done. At
exploration, his femoral artery was again thrombosed and thrombus had extended into
his iliac artery. Dissection into the retroperitoneal area was required in order to remove
the entire thrombus. At surgery tissues were described as brown and necrotic.
Pathological examination ofthrombus material again demonstrated mucormycosis. A
KOH preparation ofthe material (ground) demonstrated numerous very large hyphal
elements suggestive of Rhizopus or Mucor, as well as smaller hyphal elements with
yeast forms suggestive ofCandida. The patient was persistently acidemic, and expired
four days after his leg amputation. Cultures of the material obtained at amputation
grew both Rhizopus oryzae and Candida tropicalis.
at AM ,Ss e < - 3 w . +.
..... FIG. 2. A higher power
iN view of the same material
stained with silver shows
large-diameter hyphae
branching at wide angles.
Note that an occasional
structure resembling a sep-
tum (arrow) may be seen in
some Mucor or Rhizopus
species. This may be a
hyphal fold or rarely a true
,'i- . :.** . :. : § ,,,, .'septum.
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FIG. 3. A slide prepara-
tion of cultured Rhizopus
oryzae demonstrates sporan-
gia (spherical spore-contain-
ing structures) and rhizoids
,4 (root-like structures) at the
A opposite end.
APHYSICIAN: How did Serratia fit in the picture? Was it a predisposing infection?
DR. JOHN RYAN (Chief, Infectious Diseases, West Haven Veterans Administration
Medical Center): I would like to comment on that. When we first saw him two days
after his mediastinal debridement, he was clinically toxic and both his toes were blue.
He was still on high doses ofvasopressors and his course was suggestive of sepsis. He
had positive blood cultures forSerratia, and there was heavydrainage ofmaterial from
the sternal wound. It seems more likely that the fungal pathogen was a superinfec-
tion.
DR. PATTERSON: I agree. He had been on broad-spectrum antibiotics before and after
the Serratia infection. These factors may well have predisposed him to fungal
superinfection, along with several other risk factors, which we shall discuss further.
DISCUSSION
Mucormycosis is a general term referring to mycotic infections caused by fungi in
the order Mucorales. The three genera that we most commonly encounter clinically
are Rhizopus, Absidia, and Mucor. Rhizopus oryzae is a prominent member of this
group and Rhizopus species are the usual pathogens in man. Typically, the risk factors
for serious infection include diabetes mellitus and systemic acidosis. Hematologic
malignancies, uremia, sepsis, and burns also predispose to infections with these
organisms [1,2]. It has been suggested that acidosis may be the important factor in
these disease states.
Rhinocerebral mucormycosis is probably the most common manifestation of such
infections, typically occurring in diabetics with systemic metabolic acidosis. The initial
infection is usually nasal, advancing through the retroorbital regions and into the
brain, where it causes parenchymal infarction by thrombus formation. The diagnosis
requires tissue biopsy to demonstrate tissue invasion and cannot be made by culture
alone. Pulmonary mucormycosis is most common in patients with hematologic
malignancies, but can also be seen in patients with the other risk factors. Again, the
diagnosis is usually obtained by examining tissue biopsy specimens, or made presump-
tively by demonstrating positive sputum cultures in the presence of suggestive lung
lesions.
Cutaneous mucormycosis is uncommon, but itcertainly does occur. Possibly the first
histologically proven case was reported in 1958; it was found in a diabetic ulcer ofthe
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lower extremity and resolved after several months of potassium iodide therapy [3].
Subsequent case reports haveemphasized the importanceofmucormycosis in diabetics
with leg ulcers [4,5]. Marchevsky et al. reviewed fifteen cases which were seen at
Mount Sinai Hospital in New York from 1958-1978 [6]. Four ofthese cases were skin
or subcutaneous infections. The authors noted that although cerebral and pulmonary
mucormycosis were still the most common forms of this infection, skin and subcuta-
neous infections were emerging as important new sites for mucormycosis. Cutaneous
mucormycosis can be superficial or gangrenous; usually the gangrenous cases occur in
patients who are immunocompromised.
In 1976 two post-operative immunocompromised patients were reported with
Rhizopus arrhizus abdominal wall infections, and nine other cases of gangrenous
cellulitis were reviewed [4]. By 1978-1979 there were several reports in the literature
ofRhizopus infections in association with Elastoplast (Beiersdorf, Inc., Norwalk, CT)
bandages [8,9,10]. In 1978, the Mayo Clinic Associated Hospitals reported six
patients who had Rhizopus infections and all these patients had been exposed to
Elastoplast dressings [8]. Three of these patients were not immunocompromised; they
were treated successfully with topical therapy alone. Two other children, with acute
lymphocytic leukemia, developed buttock abscesses wheredressings werecovered with
Elastoplast bandages following bone marrow biopsy procedures.
Rhizopus was found in bandages that were obtained from four different sites within
the hospital. At that point, investigators from the Centers for Disease Control (CDC)
became involved. They found that the manufacturing plant produced bandages which
were culture-positive for the same Rhizopus species. A follow-up from CDC six
months later reported 17 more cases from ten different hospitals. All implicated the
use of Elastoplast bandages to cover sterile wound dressings [9]. The lesions were
described as vesiculopustular, ulcerative, or necrotic. Only four ofthese patients were
immunocompromised. Two additional patients had sternal wound infections with
Rhizopus. Their wounds had been dressed with sterile gauze covered by elasticized
bandage [10]. One was diagnosed early by pathological examination of a skin biopsy
and he was successfully treated with local applications of amphotericin B. The other
patient was not diagnosed until autopsy, which demonstrated pulmonary vessels and
carotid arteries thrombosed by mucormycosis. The respiratory care unit in which these
patients were cared for had Elastoplast bandages which were culture-positive for
Rhizopus. However, this situation was found in only four of ten hospitals so
investigated.
Diabetes appears to be an independent risk factor fordevelopmentofmucormycosis.
Diabetics have developed similar infections under wound dressings which did not
include Elastoplast [15,16]. A spontaneous inguinal abscess caused by Rhizopus
rhizopodiformis was reported in 1983 [17]. It occurred in a diabetic renal transplant
patient and was not associated with instrumentation. The patient was cured bysurgical
drainage and systemic administration ofamphotericin B.
When the bandage problem became evident, the manufacturer took preventive
measures and began irradiation of their Elastoplast bandages before distribution.
There were additional case reports [11,12,13,14], but the association ofinfection with
Elastoplast decreased markedly after 1979. Since 1979 the manufacturer has added
antifungal preservatives and anti-oxidants to their adhesives [personal communica-
tion]. Their industrial microbiologist does routine stability testing on bandages and
checks their lots at three, six, nine, twenty-four, and thirty-six mpnths to determine if
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they contain any viable fungi. Test bandages are also inoculated with Rhizopus,
Aspergillus, and Candida species. No significant growth of fungus should occur after
inoculation.
The Elastoplast package insert now clearly indicates that the bandages are neither
sterile nor are they to be used on open wounds. Unfortunately, after opening, bandages
are often kept unwrapped in ward refrigerators. At our institution cultures ofone such
Elastoplast bandage kept open in a refrigerator grew 13 colonies of Penicillium spp.,
three colonies ofPaecilomyces, two colonies ofCandidaparapsilosis, and two colonies
of Aspergillus spp. A cultured Elastoplast bandage from a previously unopened
package was sterile except for one colony of Rhodotorula rubra, quite possibly a
culture contaminant.
There have been two reports of cutaneous mucormycosis related to intravenous
catheter sites. One infection occurred in a child with acute lymphocytic leukemia and
resolved with local debridement and amphotericin B [7]. Another infection occurred in
a diabetic, necessitating amputation; the outcome was fatal nevertheless [17]. Intra-
aortic balloom pump infections do occur, but they are probably underreported. The
incidence noted in previous reviews ranges from 1-12 percent [18,19]. They may occur
when the IABP is in place or after removal in the form ofa subsequent wound abscess.
The organisms that have been involved are usually Gram-negative rods and staphylo-
cocci. We could not find a single report of IABP-related fungal infection, although
Candida species are known causes ofintra-arterial catheter infections [20].
Therapy of patients with gangrenous cutaneous mucormycosis is difficult. It
involves debridement and sometimes amputation of the involved area, as well as
high-dose (0.7-1.0 mg/kg/day) systemic amphotericin B [1,5].
DR. RYAN: I am concerned about the use ofthe elasticized bandages in our hospital.
DR. FRANK BIA (Associate Professor of Medicine): One of the problems is that
Elastoplast bandages are left open in refrigerators on the wards; mold is easily picked
up that way. The manufacturer cannot be implicated in such a case since they do
extensive quality control testing, and an unprotected roll can lie around for weeks.
A PHYSICIAN: Has any work been done to try to determine what it is in the Elastoplast
that supports the growth ofthese fungi?
DR. PATTERSON: It is simply not known. It would be interesting because fungi have
been noted in otherwound dressings as well. The roll which grew the multiple fungi has
been discarded. We suggest that bandages be kept in their packages, rather than
uncovered in the ward refrigerators.
COMMENT
A patient with a history of diabetes mellitus and intermittent acidemia developed
post-operative Serratia marcescens sepsis from infection of his sternal and inguinal
wounds. Recurrent thrombosis of his left femoral artery followed, and ultimately a
pathologic specimen wasdiagnostic for mucormycosis. Cultures grewRhizopus oryzae
and, although he was treated with both high-dose amphotericin B and underwent
amputation, he was persistently acidemic and expired.
In the clinical setting of recurrent thrombosis, especially following arterial instru-
mentation, such fungi are suspect since they are notorious vascular invaders. Diagnosis
is usually made by histopathological examination of tissue specimens rather than by
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culture. Tissue samples, and thrombus material in particular, should be examined
early ifthese organisms are suspected.
The well-known risk factors for mucormycosis, including diabetes mellitus, acidosis,
and uremia, were present in this patient. He had two additional risk factors, arterial
instrumentation and Elastoplast wound dressings, both ofwhich have been recognized
more recently in the literature as nosocomial risk factors for fungal infection. The
association ofbandages and wound dressings with mucormycosis infections is immuno-
compromised patients has been particularly striking.
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